Langenfeld, Germany, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global facilitator of international medical care, announced today a timely initiative aimed at improving access to advanced ...
Using a real-world, nationwide electronic health record–derived deidentified database of 38,048 patients with advanced NSCLC, we trained binary prediction algorithms to predict likelihood of 12-month ...
What Is Hyrnuo, and Why Does It Matter? Hyrnuo (sevabertinib) is a new oral medicine for adults with advanced nonsquamous non-small-cell lung cancer (NSCLC) carrying a specific genetic change known as ...
This fact sheet explains how lung cancer is staged, and what each stage means. Lung cancer staging can be complex, but this fact sheet is intended for patient education. Our easy-to-read fact sheets ...
NCCN guidelines are evidence-informed, consensus-driven, and influential in US payer policies, with a focus on multidisciplinary representation and global adaptations. ESMO guidelines reduce care ...
Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell lung cancer. The OptiTROP-Lung05 study is the first phase 3 trial of an ...
A Frederick-based hospital has developed an aggressive screening and treatment program for lung cancer and now, it’s beating national averages for early detection and treatment. Today, Frederick ...
In his 20-year research career in Colorado, University of Colorado Cancer Center member D. Ross Camidge, MD, PhD, has published nearly 400 academic papers. But perhaps none have been so personal to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback